Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Queizan

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
British Journal of Haematology|January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPICarlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
British Journal of Haematology|July 7, 2018
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithmCarlos Montalbán, Antonio Díaz-López, Alejandro Martín, et al.
British Journal of Haematology|January 21, 2017
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β<sub>2</sub> -microglobulin yields a more accurate GELTAMO-IPICarlos Montalbán, Antonio Díaz-López, Ivan Dlouhy, et al.
Pageof 2